These publications are available for immediate purchase and download (via a code on receipt). If download is not available, issue can be emailed within 24 hours. Payment is accepted via VISA, Mastercard, and American Express. Orders can also be placed for payment via wire/bank transfer. Please contact us at with any questions.

NeuroPerspectiveborder.jpg NeuroPerspective

Our bimonthly journal covering the cutting-edge therapies being developed for disorders of the central nervous system, including Alzheimer's, Parkinson's, TBI, schizophrenia, and depression--and the companies pursuing them. It enjoys worldwide readership and kudoes for its 'no-holds-barred' evaluations. One year, six issue subscription cycle. Academic and startup rates available: email us at

NL2021thumb NeuroLicensing 2021 $4,200.00

NeuroLicensing 2021 is completely revised and updated, analyzing current trends in CNS deal parameters, providing candid assessments of the major and midsize companies involved in CNS inlicensing. Licensing agendas and performance are reviewed and appraised. NL 2021 provides a vital resource for licensing efforts on both sides of the transaction, both licensors and licensees. 104 pages. Released February 2021. Five-user (within one Company) subscription license:$4200.


Single issues of NeuroPerspective can also be purchased 'a la carte.' Click on that category to see the choices that are currently available.

Larger user group subscription options can be viewed on that Menu Page.